Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 2176 AL 2190

Late-stage Parkinson disease

Coelho M, Ferreira JJ.

Nat Rev Neurol. 2012 Aug;8(8):435-42. doi: 10.1038/nrneurol.2012.126. Epub 2012 Jul 10.

Managing the patient with newly diagnosed Parkinson disease

Singer C.

Cleve Clin J Med. 2012 Jul;79 Suppl 2:S3-7. doi: 10.3949/ccjm.79.s2a.01.

Off spells and dyskinesias: pharmacologic management of motor complications

Khan TS.

Cleve Clin J Med. 2012 Jul;79 Suppl 2:S8-13. doi: 10.3949/ccjm.79.s2a.02.

The influence of residual nor-β-CFT in 11C CFT injection on the Parkinson disease diagnosis: a 11C CFT PET study

Huang T, Wang H, Tang G, Liang X, Shi X, Zhang X.

Clin Nucl Med. 2012 Aug;37(8):743-7. doi: 10.1097/RLU.0b013e31824c5fae.

Physiotherapy versus placebo or no intervention in Parkinson's disease

Tomlinson CL, Patel S, Meek C, Clarke CE, Stowe R, Shah L, Sackley CM, Deane KH, Herd CP, Wheatley K, Ives N.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD002817. doi: 10.1002/14651858.CD002817.pub2.

Genetic heterogeneity in Parkinson disease: the meaning of GWAS and replication studies

Pastor P.

Neurology. 2012 Aug 14;79(7):619-20. doi: 10.1212/WNL.0b013e318264e3d2. Epub 2012 Jul 11.

Deep brain stimulation for psychiatric disease: contributions and validity of animal models

Hamani C, Temel Y.

Sci Transl Med. 2012 Jul 11;4(142):142rv8. doi: 10.1126/scitranslmed.3003722.

Rehabilitation or compensation: time for a fresh perspective on speech and language therapy for dysphagia and Parkinson's disease?

Smith SK, Roddam H, Sheldrick H.

Int J Lang Commun Disord. 2012 Jul-Aug;47(4):351-64. doi: 10.1111/j.1460-6984.2011.00093.x. Epub 2012 Apr 11.

[Decreased myocardial uptake of meta-iodobenzylguanidine in an autopsy-confirmed case of corticobasal degeneration with Lewy bodies restricted to the sympathetic ganglia]

Mori K, Iwasaki Y, Ito M, Mimuro M, Yoshida M.

Rinsho Shinkeigaku. 2012;52(6):405-10. doi: 10.5692/clinicalneurol.52.405.

Olfactory impairment in familial ataxias

Moscovich M, Munhoz RP, Teive HA, Raskin S, Carvalho Mde J, Barbosa ER, Ranvaud R, Liu J, McFarland K, Ashizawa T, Lees AJ, Silveira-Moriyama L.

J Neurol Neurosurg Psychiatry. 2012 Oct;83(10):970-4. doi: 10.1136/jnnp-2012-302770. Epub 2012 Jul 11.

Pathogenesis of achalasia cardia

Ghoshal UC, Daschakraborty SB, Singh R.

World J Gastroenterol. 2012 Jun 28;18(24):3050-7. doi: 10.3748/wjg.v18.i24.3050.

Stem cells and regenerative therapies for Parkinson's disease

Farrell K, Barker RA.

Degener Neurol Neuromuscul Dis. 2012 Jul 15;2:79-92. doi: 10.2147/DNND.S16087. eCollection 2012.

Validity of a screening instrument for neurologic disability in resource-poor African communities

Bower JH, Mwendo E, Walker R, Maro V, Enquosellasie F, Ali S.

J Neurol Sci. 2012 Sep 15;320(1-2):52-5. doi: 10.1016/j.jns.2012.06.007. Epub 2012 Jul 11.

Metal imaging in neurodegenerative diseases

Bourassa MW, Miller LM.

Metallomics. 2012 Aug;4(8):721-38. doi: 10.1039/c2mt20052j. Epub 2012 Jul 16.

Attempted suicide under high dose dopaminergic therapy including apomorphine

Struhal W, Guger M, Hödl S, Ung SC, Bach M, Ransmayr G.

Wien Klin Wochenschr. 2012 Jul;124(13-14):461-3. doi: 10.1007/s00508-012-0202-5. Epub 2012 Jul 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias